Silencing early viral replication in macrophages and dendritic cells effectively suppresses flavivirus encephalitis

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Ye, Chunting ^a   Abraham, Sojan ^a   Wu, Haoquan ^a   Shankar, Premlata ^a   Manjunath, N ^a  

^a Paul L Foster School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; RABIES VIRUS GLYCOPROTEIN 9 MER POLYARGININE RESIDUE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE COURSE; FLAVIVIRUS INFECTION; GENE DELIVERY SYSTEM; GENE SILENCING; GENE TARGETING; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MOUSE; NONHUMAN; RNA ANALYSIS; ST LOUIS FLAVIVIRUS; SURVIVAL RATE; TARGET CELL; VIRUS ENCEPHALITIS; VIRUS GENOME; VIRUS INHIBITION; VIRUS REPLICATION; WEST NILE FLAVIVIRUS; ANIMAL; CELL LINE; DRUG EFFECT; ENCEPHALITIS; FLAVIVIRUS; GENETICS; INTRAVENOUS DRUG ADMINISTRATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; VIROLOGY;

FLAVIVIRUS; MUS; ST. LOUIS ENCEPHALITIS VIRUS; WEST NILE VIRUS;

ANIMALS; CELL LINE; CONSERVED SEQUENCE; DENDRITIC CELLS; ENCEPHALITIS; ENCEPHALITIS VIRUS, ST. LOUIS; FLAVIVIRUS; FLAVIVIRUS INFECTIONS; GENE SILENCING; INJECTIONS, INTRAVENOUS; MACROPHAGES; MICE; RNA, SMALL INTERFERING; VIRUS REPLICATION; WEST NILE VIRUS;

EID: 79952659281     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017889     Document Type: Article

References (23)

1. Fields BN, Knipe DM, Howley PM, eds. Field's Virology. (Lippincott-Raven, Philadelphia,) pp. 931-952.
2. Biggerstaff BJ, Petersen LR, (2003) Estimated risk of transmission of the West Nile virus through blood transfusion in the US, 2002. Transfusion 43: 1007-1017.
3. Tyler KL, (2004) West Nile virus infection in the United States. Arch Neurol 61: 1190-1195.
4. Solomon T, (2004) Flavivirus encephalitis. N Engl J Med 351: 370-378.
5. Haasnoot J, Westerhout EM, Berkhout B, (2007) RNA interference against viruses: strike and counterstrike. Nat Biotechnol 25: 1435-1443.
6. Manjunath N, Kumar P, Lee SK, Shankar P, (2006) Interfering antiviral immunity: application, subversion, hope? Trends Immunol 27: 328-335.
7. Lares MR, Rossi JJ, Ouellet DL., RNAi and small interfering RNAs in human disease therapeutic applications. Trends Biotechnol 28: 570-579.
8. Kirchhoff F, (2008) Silencing HIV-1 In Vivo. Cell 134: 566-568.
9. Grimm D, Kay MA, (2007) Therapeutic application of RNAi: is mRNA targeting finally ready for prime time? J Clin Invest 117: 3633-3641.
10. Kumar P, Wu H, McBride JL, Jung KE, Kim MH, et al. (2007) Transvascular delivery of small interfering RNA to the central nervous system. Nature 448: 39-43.
11. Kim SS, Ye C, Kumar P, Chiu I, Subramanya S, et al. Targeted delivery of siRNA to macrophages for anti-inflammatory treatment. Mol Ther 18: 993-1001.
12. Diamond MS, Shrestha B, Mehlhop E, Sitati E, Engle M, (2003) Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus. Viral Immunol 16: 259-278.
13. Lim PY, Louie KL, Styer LM, Shi PY, Bernard KA., Viral pathogenesis in mice is similar for West Nile virus derived from mosquito and mammalian cells. Virology 400: 93-103.
14. Rios M, Zhang MJ, Grinev A, Srinivasan K, Daniel S, et al. (2006) Monocytes-macrophages are a potential target in human infection with West Nile virus through blood transfusion. Transfusion 46: 659-667.
15. Kumar P, Lee SK, Shankar P, Manjunath N, (2006) A single siRNA suppresses fatal encephalitis induced by two different flaviviruses. PLoS Med 3: e96.
16. Manjunath N, Wu H, Subramanya S, Shankar P, (2009) Lentiviral delivery of short hairpin RNAs. Adv Drug Deliv Rev 61: 732-745.
17. Diamond MS, Shrestha B, Marri A, Mahan D, Engle M, (2003) B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol 77: 2578-2586.
18. Bai F, Wang T, Pal U, Bao F, Gould LH, et al. (2005) Use of RNA interference to prevent lethal murine west nile virus infection. J Infect Dis 191: 1148-1154.
19. von Eije KJ, ter Brake O, Berkhout B, (2008) Human immunodeficiency virus type 1 escape is restricted when conserved genome sequences are targeted by RNA interference. J Virol 82: 2895-2903.
20. ter Brake O, t Hooft K, Liu YP, Centlivre M, von Eije KJ, et al. (2008) Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition. Mol Ther 16: 557-564.
21. Bai F, Kong KF, Dai J, Qian F, Zhang L, et al. A paradoxical role for neutrophils in the pathogenesis of West Nile virus. J Infect Dis 202: 1804-1812.
22. Su X, Matthay MA, Malik AB., Requisite role of the cholinergic alpha7 nicotinic acetylcholine receptor pathway in suppressing Gram-negative sepsis-induced acute lung inflammatory injury. J Immunol 184: 401-410.
23. Samuel MA, Diamond MS, (2006) Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion. J Virol 80: 9349-9360.